A phase I/II study of the safety and efficacy of [177Lu]Lu-satoreotide tetraxetan in advanced somatostatin receptor-positive neuroendocrine tumours - Wild, D; Grønbæk, H; Navalkissoor, S (Eur J Nucl Med Mol Imaging, 2023)